The Mediation Effects of Type 2 Diabetes Mellitus and Related Biomarkers on the Association of Metabolic Dysfunction-associated Steatotic Liver Disease and Fibrosis
Journal of Gastrointestinal and Liver Diseases · 27.03.2025 · 34 (1) · 47-54
DOI: 10.15403/jgld-5901 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, online erschienen am 27.03.2025. Verfasst von Rujun Cai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, School of Public Health, Fudan University, Shanghai; Key Laboratory of Public Health Safety (Fudan University), Ministry …. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Liver Cirrhosis, Fatty Liver. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background and Aims: Both metabolic dysfunction-associated steatotic liver disease (MASLD) and fibrosis have been associated with type 2 diabetes mellitus (T2DM), but the roles of T2DM and related biomarkers in the association between MASLD and fibrosis are yet to be fully elucidated. This study aimed at assessing whether the association between MASLD and fibrosis is mediated by T2DM.
Methods
A total of 6,060 participants from NHANES 2017-2020 were enrolled in the cross-sectional analyses. Pairwise associations among MASLD, fibrosis, T2DM, and T2DM-related biomarkers [plasma fasting glucose, hemoglobin A1c (HbA1c), serum insulin, and homeostatic model assessment for insulin resistance (HOMA-IR)] were examined, and then the extent to which MASLD progresses to fibrosis through T2DM and the biomarkers was assessed.
Results
We found a higher risk of T2DM and higher levels of T2DM-related biomarkers were associated with MASLD. Moreover, T2DM and higher levels of T2DM-related biomarkers were positively associated with fibrosis risk. T2DM, plasma fasting glucose, HbA1c, serum insulin, and HOMA-IR mediated 10.1%, 9.99%, 10.5%, 5.98%, and 7.28% of the association between MASLD and fibrosis, respectively. In addition, the mediation effect of T2DM varied in different groups of age, body mass index, and antidiabetic medication.
Conclusions
T2DM and T2DM-related biomarkers partly mediated the association between MASLD and fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, School of Public Health, Fudan University, Shanghai; Key Laboratory of Public Health Safety (Fudan University), Ministry of Education, Shanghai, China. . npjjzxcrj@163.com.
- State Key Laboratory of Genetic Engineering, Human Phenome Institute, School of Life Sciences, Fudan University, Shanghai; Fudan University Taizhou Institute of Health Sciences, Taizhou, China. zhenqiuliu@fudan.edu.cn.
- Department of Epidemiology, School of Public Health, Fudan University, Shanghai; Key Laboratory of Public Health Safety (Fudan University), Ministry of Education, Shanghai, China. 20111020010@fudan.edu.cn.
- Department of Epidemiology, School of Public Health, Fudan University, Shanghai; Key Laboratory of Public Health Safety (Fudan University), Ministry of Education, Shanghai, China. 22111020048@m.fudan.edu.cn.
- Department of Epidemiology, School of Public Health, Fudan University, Shanghai; Key Laboratory of Public Health Safety (Fudan University), Ministry of Education, Shanghai, China. 22211020048@fudan.edu.cn.
- Department of Epidemiology, School of Public Health, Fudan University, Shanghai; Key Laboratory of Public Health Safety (Fudan University), Ministry of Education, Shanghai; Shanghai Institute of Infectious Disease and B…
Zitieren
APA
Cai, R., Liu, Z., Fan, H., Zhang, X., Chen, Y., & Zhang, T. (2025). The Mediation Effects of Type 2 Diabetes Mellitus and Related Biomarkers on the Association of Metabolic Dysfunction-associated Steatotic Liver Disease and Fibrosis. Journal of Gastrointestinal and Liver Diseases, 34(1), 47-54. https://doi.org/10.15403/jgld-5901
Vancouver
Cai R, Liu Z, Fan H, Zhang X, Chen Y, Zhang T. The Mediation Effects of Type 2 Diabetes Mellitus and Related Biomarkers on the Association of Metabolic Dysfunction-associated Steatotic Liver Disease and Fibrosis. Journal of Gastrointestinal and Liver Diseases. 2025;34(1):47-54. doi:10.15403/jgld-5901
BibTeX
@article{Cai2025,
author = {Cai, Rujun and Liu, Zhenqiu and Fan, Hong and Zhang, Xin and Chen, Yizhou and Zhang, Tiejun},
title = {The Mediation Effects of Type 2 Diabetes Mellitus and Related Biomarkers on the Association of Metabolic Dysfunction-associated Steatotic Liver Disease and Fibrosis},
journal = {Journal of Gastrointestinal and Liver Diseases},
year = {2025},
volume = {34},
number = {1},
pages = {47--54},
doi = {10.15403/jgld-5901}
}
EUVIMED